Closer association of IA-2 humoral autoreactivity with HLA DR3/4 than DQB1*0201/*0302 in Korean T1D patients.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Park Y;Park Y; Tait BD; Kawasaki E; Rowley M; Mackay IR
  • Source:
    Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2004 Dec; Vol. 1037, pp. 104-9.
  • Publication Type:
    Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: New York Academy of Sciences Country of Publication: United States NLM ID: 7506858 Publication Model: Print Cited Medium: Print ISSN: 0077-8923 (Print) Linking ISSN: 00778923 NLM ISO Abbreviation: Ann N Y Acad Sci Subsets: MEDLINE
    • Publication Information:
      Publication: 2006- : New York, NY : Malden, MA : New York Academy of Sciences ; Blackwell
      Original Publication: New York, The Academy.
    • Subject Terms:
    • Abstract:
      The HLA DQB1*0302 allele on DR4 haplotypes is a well-known marker for T1D susceptibility. The contribution of this DQ molecule to overall disease susceptibility may be genotype dependent. On Asian DR4 haplotypes, not only DQB1*0302, but also DQB1*0401 confer susceptibility to T1D, which is mediated by DRB1*0405 on the same haplotype. To analyze further the association of DQB1*0302 and DQB1*0401 haplotypes in Asian patients with T1D, we investigated HLA DR and DQ alleles with the presence or the persistence of GAD, ICA, and IA-2 autoantibodies in 121 Korean T1D patients. In Korean patients, there was an association of IA-2 autoantibodies with DR4 as well as DR3, but not with DQA1*0301-DQB1*0302. GAD autoantibodies were not associated with the DR3-DQB1*0201, DQA1*0301-DQB1*0302, or DR4. In this low-risk population, autoantibodies to islet-cell antigens were associated with different HLA molecules. In different populations, the immune response to different beta cell autoantigens is mediated via varying HLA class II molecules from different loci. Design of the antigen-specific immunointervention trials should take into account such HLA DR and DQ association.
    • Accession Number:
      0 (Autoantibodies)
      0 (HLA-DQ Antigens)
      0 (HLA-DR3 Antigen)
      0 (HLA-DR4 Antigen)
      0 (ICA512 autoantibody)
      EC 4.1.1.15 (Glutamate Decarboxylase)
    • Publication Date:
      Date Created: 20050209 Date Completed: 20050503 Latest Revision: 20221207
    • Publication Date:
      20231215
    • Accession Number:
      10.1196/annals.1337.015
    • Accession Number:
      15699500